Reaction
Therapeutic Product Ineffective For Unapproved Indication reporting signals
As of the last recalculation, Therapeutic Product Ineffective For Unapproved Indication appears in 453 FAERS reports alongside 6 co-occurring drug terms. The strongest observed disproportionality signal is DALFAMPRIDINE (PRR 29.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dalfampridine | 42 | 29.5 | 29.6 |
| Vigabatrin | 9 | 28.9 | 28.9 |
| Zonisamide | 9 | 28.5 | 28.5 |
| Clobazam | 11 | 21.2 | 21.2 |
| Brentuximab Vedotin | 4 | 18.1 | 18.1 |
| Cannabidiol | 9 | 18.0 | 18.0 |